(Q40637350)

22 September 2017

title

Vinorelbine as first-line chemotherapy for advanced breast cancer in women 60 years of age or older (English)

1 reference

22 September 2017

1 reference

C Vogel

1

1 reference

22 September 2017

M O'Rourke

2

1 reference

22 September 2017

E Winer

3

1 reference

22 September 2017

H Hochster

4

1 reference

22 September 2017

A Chang

5

1 reference

22 September 2017

B Adamkiewicz

6

1 reference

22 September 2017

R White

7

1 reference

22 September 2017

C McGuirt

8

1 reference

22 September 2017

publication date

1 April 1999

1 reference

22 September 2017

1 reference

22 September 2017

volume

10

1 reference

22 September 2017

issue

4

1 reference

22 September 2017

page(s)

397-402

1 reference

Breast cancer in aging women. A population-based study of contrasts in stage, surgery, and survival

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008364222793

7 January 2021

Patterns of breast cancer care in the elderly

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008364222793

7 January 2021

Phase II trial of weekly i.v. vinorelbine as a single agent in first-line advanced breast cancer chemotherapy. The Latin-American experience

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008364222793

7 January 2021

Phase II trial of weekly intravenous vinorelbine in first-line advanced breast cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008364222793

7 January 2021

Phase II trial of weekly IV vinorelbine in first-line advanced breast cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008364222793

7 January 2021

Vinorelbine as first-line chemotherapy for metastatic breast carcinoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008364222793

7 January 2021

A phase II, multicentre, UK study of vinorelbine in advanced breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008364222793

7 January 2021

Intravenous vinorelbine as first-line and second-line therapy in advanced breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008364222793

7 January 2021

Randomized comparison of vinorelbine and melphalan in anthracycline-refractory advanced breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008364222793

7 January 2021

Pharmacokinetics and tolerance of vinorelbine in elderly patients with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008364222793

7 January 2021

Combination chemotherapy compared to tamoxifen as initial therapy for stage IV breast cancer in elderly women

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008364222793

7 January 2021

"Classical" CMF versus a 3-weekly intravenous CMF schedule in postmenopausal patients with advanced breast cancer. An EORTC Breast Cancer Co-operative Group Phase III Trial (10808)

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008364222793

7 January 2021

Cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy in women more than 65 years old with advanced breast cancer: the elimination of age trends in toxicity by using doses based on creatinine clearance

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008364222793

7 January 2021

Phase II study of mitoxantrone, 5-fluorouracil, and levo-leucovorin (MLF) in elderly advanced breast cancer patients

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008364222793

7 January 2021

Chemotherapy of metastatic breast cancer in the elderly. The Piedmont Oncology Association experience [see comment].

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008364222793

7 January 2021

Identifiers

DOI

10.1023/A:1008364222793

1 reference

22 September 2017

1 reference